Comparison of trials
Response . | Rajkumar et al,26 % (N = 34) . | BiRD, % (N = 72) . | Lacy et al,31 % (N = 34) . |
---|---|---|---|
Complete response | 6 | 38.9 | 18 |
Near-complete response | NA | 13.9 | NA |
Very good partial response | 32 | 20.8 | 38 |
Partial response | 53 | 16.7 | 35 |
Minor response | 6 | 5.6 | NA |
No response | 3 | 0 | NA |
Nonevaluable patients | NA | 4.2 | NA |
Overall response | 91 | 90.3 | 91 |
Total | 100 | 100 | — |
Response . | Rajkumar et al,26 % (N = 34) . | BiRD, % (N = 72) . | Lacy et al,31 % (N = 34) . |
---|---|---|---|
Complete response | 6 | 38.9 | 18 |
Near-complete response | NA | 13.9 | NA |
Very good partial response | 32 | 20.8 | 38 |
Partial response | 53 | 16.7 | 35 |
Minor response | 6 | 5.6 | NA |
No response | 3 | 0 | NA |
Nonevaluable patients | NA | 4.2 | NA |
Overall response | 91 | 90.3 | 91 |
Total | 100 | 100 | — |
Rajkumar et al and Lacy et al: Durie-Salmon stage III, 47%; International Staging System stage III, 12%.
BIRD: Durie-Salmon stage III, 44%; International Staging System stage III, 18%.
NA indicates not available; and —, not applicable.